ArticleNaunyn-Schmiedeberg's archives of pharmacology1996

Effects of a myosin light chain kinase inhibitor, wortmannin, on cytoplasmic Ca2+ levels, myosin light chain phosphorylation and force in vascular smooth muscle.

M Takayama et al.PubMed ↗Publisher ↗

No numbers read from the abstract.